Propofol versus midazolam for sedation during radiofrequency ablation in patients with hepatocellular carcinoma.
Naoya KanogawaSadahisa OgasawaraYoshihiko OokaMasanori InoueToru WakamatsuMasayuki YokoyamaSusumu MarutaHidemi UnozawaTerunao IwanagaTakafumi SakumaNaoto FujitaKeisuke KorokiHiroaki KanzakiTakahiro MaedaKazufumi KobayashiSoichiro KiyonoMasato NakamuraTakayuki KondoTomoko SaitoTenyu MotoyamaEiichiro SuzukiShingo NakamotoAkinobu TawadaTetsuhiro ChibaMakoto AraiTatsuo KandaHitoshi MaruyamaJun KatoRyo TakemuraNatsuko Nozaki-TaguchiIsono ShirohOsamu YokosukaNaoya KatoPublished in: JGH open : an open access journal of gastroenterology and hepatology (2020)
Patient satisfaction was almost identical in patients receiving propofol and midazolam sedation during RFA. Propofol sedation resulted in reduced recovery time compared with midazolam sedation in patients with HCC. The safety profiles of both propofol and midazolam sedation during and after RFA were acceptable.